INTRODUCTION: The aim of this study is to determine the course of COVID 19 in patients with autoimmune diseases (AD), and to investigate the severity of disease, need for intensive care and mortality in these patients.
METHODS: In this study, 125 patients who had COVİD-19 and were diagnosed with autoimmune disease before, were evaluated retrospectively. Comorbidities, demographics, laboratory findings, rates of mortality, intensive care unit admission, administration of immunosuppressive treatments and length of hospital stay were collected.
RESULTS: All patients had a positive SARS-CoV-2 PCR test. The most common autoimmune diseases were rheumatoid arthritis, Hashimoto's thyroiditis and inflammatory bowel diseases.
DISCUSSION AND CONCLUSION: Our results have shown diabetes mellitus (DM), neutrophil lymphocyte ratio and platelet count were found to be an independent risk factor for mortality in patients with AD.